NCT04622917View on ClinicalTrials.gov

Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 10, 2019

Primary Completion Date

June 20, 2022

Study Completion Date

May 31, 2023

Conditions
Rhinitis, Allergic, SeasonalHay FeverPollen AllergyAllergic Rhinitis
Interventions
DRUG

MethylPREDNISolone 40 Mg/mL Injectable Suspension

intramuscular injection

DRUG

NaCl 9 MG/ML Injectable Solution

Intramuscular injection

Trial Locations (1)

22242

Department of Lung-and Allergy Research, Lund

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT04622917 - Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis. | Biotech Hunter | Biotech Hunter